APA (7th ed.) Citation

KM, G., Z, S., LG, T., A, F., C, B., & K, B. (2018). Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma. Pediatric blood & cancer, 65(2), . https://doi.org/10.1002/pbc.26781

Chicago Style (17th ed.) Citation

KM, Gabor, Sapi Z, Tiszlavicz LG, Fige A, Bereczki C, and Bartyik K. "Sirolimus Therapy in the Treatment of Pseudomyogenic Hemangioendothelioma." Pediatric Blood & Cancer 65, no. 2 (2018). https://doi.org/10.1002/pbc.26781.

MLA (9th ed.) Citation

KM, Gabor, et al. "Sirolimus Therapy in the Treatment of Pseudomyogenic Hemangioendothelioma." Pediatric Blood & Cancer, vol. 65, no. 2, 2018, https://doi.org/10.1002/pbc.26781.